NXS 3.33% 15.5¢ next science limited

Ann: Investor Presentation, page-13

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 142 Posts.
    lightbulb Created with Sketch. 33
    @Puddyeater2 I think Bactisure Wound Lavage has been approved and is available in the US, Canada, Chile, New Zealand, South Africa and Australia, BlastX Antimicrobial Wound Gel is an approved product (not exactly sure where, but I think it is in the US) and comes back under NXS' control from second quarter 2021 (see NXS' investor presentation 22 Feb 2021). Re Xperience No Rinse Anti Microbial Solution this one hasn't been approved at the moment by the US FDA. DYOR
 
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
(20min delay)
Last
15.5¢
Change
0.005(3.33%)
Mkt cap ! $45.28M
Open High Low Value Volume
15.5¢ 16.0¢ 15.0¢ $32.26K 208.9K

Buyers (Bids)

No. Vol. Price($)
1 46003 15.5¢
 

Sellers (Offers)

Price($) Vol. No.
16.0¢ 27170 2
View Market Depth
Last trade - 16.10pm 07/11/2024 (20 minute delay) ?
NXS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.